ADXN vs AEON

Addex Therapeutics Ltd vs AEON Biopharma, Inc. — Valuation Comparison 2026

ADXN

Biotechnology
Addex Therapeutics Ltd
Quality
5.5
out of 10
Value Trap
20
SAFE
Price
$6.82
Last close
Models
6/13
Active
VS

AEON

Biotechnology
AEON Biopharma, Inc.
Quality
3.3
out of 10
Value Trap
18
SAFE
Price
$0.72
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType ADXN Fair ValueADXN Upside AEON Fair ValueAEON Upside
Bayesian DCF Intrinsic $0.12 -86.6%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $13.22 +88.8% $0.21 -76.4%
Dynamic NAV Asset-Based $6.04 -11.4% $0.02 -97.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ADXN vs AEON — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ADXN vs AEON — Which Stock Is More Undervalued?

ADXN scores higher with a 5.5/10 quality rating vs AEON's 3.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Addex Therapeutics Ltd (ADXN) and AEON Biopharma, Inc. (AEON) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ADXN currently trades at $6.82 with a QOC of 5.5/10, while AEON trades at $0.72 with a QOC of 3.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).